BML 190,
BML-190,
BML190,
indomethacin morpholinylamide,
BML-190,
2854-32-2,
Indomethacin morpholinylamide,
2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-1-morpholinoethanone,
BML 190,
IMMA,
CHEMBL72631,
SR-01000075946,
Bio2_000763,
Tocris-1383,
Lopac-I-151,
AC1L1DMH,
AC1Q5KCJ,
Indomethacin morpholinamide,
CBiol_001726,
Lopac0_000685,
BSPBio_001563,
KBioGR_000283,
KBioSS_000283,
BML2-C04,
SCHEMBL8314320,
CHEBI:93649,
CTK4G1689,
KBio2_000283,
KBio2_002851,
KBio2_005419,
KBio3_000565,
KBio3_000566,
AOB2533,
BJSDNVVWJYDOLK-UHFFFAOYSA-N,
BCPP000330,
Bio1_000012,
Bio1_000501,
Bio1_000990,
Bio2_000283,
HMS1361O05,
HMS1791O05,
HMS1989O05,
HMS3267D16,
HMS3402O05,
HMS3649M07,
HMS3651P17,
HMS3676K16,
BCP02700,
BML-190/,
Indomethacin morpholinylamide, solid,
ZINC2244161,
ABP000803,
ANW-53696,
BDBM50090806,
s2854,
AKOS001233928,
BCP9000422,
CCG-204770,
CS-0853,
SB19547,
IDI1_034033,
Indomethacin morpholinylamide (BML190),
NCGC00015540-01,
NCGC00015540-02,
NCGC00015540-03,
NCGC00015540-04,
NCGC00015540-05,
NCGC00015540-06,
NCGC00025136-01,
NCGC00025136-02,
NCGC00025136-03,
NCGC00025136-04,
NCGC00025136-05,
4CA-0289,
AJ-34438,
HY-15420,
QC-10227,
AB0089786,
ST2403783,
TC-142441,
EU-0100685,
I-151,
SW219196-1,
A11938,
S-7737,
J-017120,
SR-01000075946-1,
SR-01000075946-3,
SR-01000075946-5,
BRD-K94379058-001-02-7,
BRD-K94379058-001-03-5,
N-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetyl]morpholine,
1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-3-[(morpholinocarbonyl)methyl]-indole,
2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-1-morpholinoethan-1-one,
2-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-morpholin-4-yl-ethanone,
2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-1-morpholin-4-ylethanone,
BML 190;2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-1-morpholinoethanone,
BML 190?2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-1-morpholinoethanone,
Ethanone, 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)-,
Ethanone,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)-,
BML-190|Indomethacin morpholinylamide|IMMA|1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1-[2-(4-morpholinyl)-2-oxoethyl]-1H-indole,
C23H23ClN2O4,
BML190,
CID2415,
C23-H23-Cl-N2-O4,
AR-1C5951,
BRN 1230853,
B1425,
C471852,
4-((2-(p-Chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl)acetyl)morpholine,
Morpholine, 4-((2-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl)acetyl)-,
1H-Indole, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1-(2-(4-morpholinyl)-2-oxoethyl)-,
29426-52-6,